{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:02:32Z","timestamp":1792299752926,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T00:00:00Z","timestamp":1622937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T00:00:00Z","timestamp":1622937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s41030-021-00161-w","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T11:02:21Z","timestamp":1622977341000},"page":"309-324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8300-751X","authenticated-orcid":false,"given":"Andrea S.","family":"Melani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albano","family":"Simona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Armati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriana","family":"d\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bargagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,6]]},"reference":[{"issue":"6","key":"161_CR1","first-page":"1052","volume":"37","author":"P Brito-Zer\u00f3n","year":"2019","unstructured":"Brito-Zer\u00f3n P, Kostov B, Superville D, Baughman RP, Ramos-Casals M, Autoimmune Big Data Study Group. Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants. Clin Exp Rheumatol. 2019;37(6):1052\u201364.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"161_CR2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","volume":"6","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389\u2013402.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"161_CR3","doi-asserted-by":"publisher","first-page":"1602419","DOI":"10.1183\/13993003.02419-2016","volume":"50","author":"B Duchemann","year":"2017","unstructured":"Duchemann B, Annesi-Maesano I, Jacobe NC, et al. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J. 2017;50(2):1602419. https:\/\/doi.org\/10.1183\/13993003.02419-2016.","journal-title":"Eur Respir J"},{"key":"161_CR4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1183\/09031936.96.09010047","volume":"9","author":"C Prior","year":"1996","unstructured":"Prior C, Knight RA, Herold M. Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J. 1996;9:47\u201355.","journal-title":"Eur Respir J"},{"issue":"9","key":"161_CR5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/1744666X.2016.1181541","volume":"12","author":"F Cinetto","year":"2016","unstructured":"Cinetto F, Agostini C. Advances in understanding the immunopathology of sarcoidosis and implications on therapy. Exp Rev Clin Immunol. 2016;12(9):973\u201388.","journal-title":"Exp Rev Clin Immunol"},{"key":"161_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2017.12.012","volume":"87","author":"JR Miedema","year":"2018","unstructured":"Miedema JR, Kaiser Y, Broos CE, Wijsenbeek MS, Grunewald J, Kool M. Th17-lineage cells in pulmonary\u00a0sarcoidosis\u00a0and Lofgren\u2019s syndrome: Friend or foe? J Autoimmun. 2018;87:82\u201396. https:\/\/doi.org\/10.1016\/j.jaut.2017.12.012 ((Epub 2018 Jan 5.PMID:\u00a029310925)).","journal-title":"J Autoimmun"},{"issue":"12","key":"161_CR7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","volume":"170","author":"LS Newman","year":"2004","unstructured":"Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170(12):1324\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"161_CR8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1183\/09031936.00002607","volume":"30","author":"D Gupta","year":"2007","unstructured":"Gupta D, Agarwal R, Aggarwal AN, et al. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J. 2007;30(3):508\u201316.","journal-title":"Eur Respir J"},{"issue":"3","key":"161_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.mcna.2018.12.011","volume":"103","author":"O Llanos","year":"2019","unstructured":"Llanos O, Hamzeh N. Sarcoidosis. Med Clin North Am. 2019;103(3):527\u201334. https:\/\/doi.org\/10.1016\/j.mcna.2018.12.011 (Epub 2019 Feb 21 PMID: 30955519).","journal-title":"Med Clin North Am"},{"issue":"10 Pt 1","key":"161_CR10","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA, et al. A Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"161_CR11","first-page":"119","volume":"29","author":"MA Judson","year":"2012","unstructured":"Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis presentation, diagnosis and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29(2):119\u201327.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"29","key":"161_CR12","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1097\/MD.0000000000007595","volume":"96","author":"J Ma\u00f1\u00e1","year":"2017","unstructured":"Ma\u00f1\u00e1 J, Rubio-Rivas M, Villalba N, et al. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine (Baltimore). 2017;96(29):7595.","journal-title":"Medicine (Baltimore)"},{"key":"161_CR13","first-page":"77","volume":"69","author":"JC Schupp","year":"2019","unstructured":"Schupp JC, Freitag-Wolf S, Bargagli E, et al. Phenotypes of organ involvement in sarcoidosis. Eur Respir J. 2019;69:77\u201385.","journal-title":"Eur Respir J"},{"issue":"2","key":"161_CR14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.chest.2018.02.003","volume":"154","author":"WE James","year":"2018","unstructured":"James WE, Koutroumpakis E, Saha B, Nathani A, Saavedra L, Yucel RM, Judson MA. Clinical features of extrapulmonary sarcoidosis without lung involvement. Chest. 2018;154(2):349\u201356.","journal-title":"Chest"},{"issue":"1","key":"161_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000481827","volume":"95","author":"T Bahmer","year":"2018","unstructured":"Bahmer T, Watz H, Develaska M, et al. Physical activity and fatigue in patients with sarcoidosis. Respiration. 2018;95(1):18\u201326.","journal-title":"Respiration"},{"issue":"3","key":"161_CR16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00408-019-00215-6","volume":"197","author":"PSP Cho","year":"2019","unstructured":"Cho PSP, Vasudevan S, Maddocks M, Spinou A, Chamberlain Mitchell S, Wood C, Jolley CJ, Birring SS. Physical inactivity in pulmonary sarcoidosis. Lung. 2019;197(3):285\u201393.","journal-title":"Lung"},{"issue":"2","key":"161_CR17","first-page":"149","volume":"16","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake GW, Costabel U, Ando M, et al. ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/world Association of Sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149\u201373.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"issue":"1","key":"161_CR18","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson MA, Costabel U, Drent M, et al. Organ Assessment Instrument Investigators, The Wasog Sarcoidosis. The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(1):19\u201327.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"8","key":"161_CR19","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, et al. on behalf of the American Thoracic Society Assembly on Clinical Problems. Diagn Detect Sarcoidosis. 2020;201(8):e26\u201351. https:\/\/doi.org\/10.1164\/rccm.202002-0251ST (PMID: 32293205).","journal-title":"Diagn Detect Sarcoidosis"},{"issue":"1","key":"161_CR20","doi-asserted-by":"publisher","first-page":"e000357","DOI":"10.1136\/bmjresp-2018-000357","volume":"6","author":"M Thillai","year":"2019","unstructured":"Thillai M, Chang W, Chaudhuri N, et al. Sarcoidosis in the UK: insights from British Thoracic Society registry data. BMJ Open Respir Res. 2019;6(1):e000357. https:\/\/doi.org\/10.1136\/bmjresp-2018-000357.","journal-title":"BMJ Open Respir Res"},{"issue":"2","key":"161_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","volume":"2","author":"SL Walsh","year":"2014","unstructured":"Walsh SL, Wells AU, Sverzellati N, et al. An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. Lancet Respir Med. 2014;2(2):123\u201330.","journal-title":"Lancet Respir Med"},{"key":"161_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2016.02.011","volume":"113","author":"MA Judson","year":"2016","unstructured":"Judson MA. The three tiers of screening for sarcoidosis organ involvement. Respir Med. 2016;113:42\u20139.","journal-title":"Respir Med"},{"issue":"5261","key":"161_CR23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","volume":"2","author":"JG Scadding","year":"1961","unstructured":"Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years\u2019 observation. Br Med J. 1961;2(5261):1165\u201372.","journal-title":"Br Med J"},{"issue":"1","key":"161_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ro.2018.12.008","volume":"54","author":"GP Reddy","year":"2019","unstructured":"Reddy GP, Ahuia J. Thoracic sarcoidosis: imaging patterns. Sem Roentgenol. 2019;54(1):59\u201365.","journal-title":"Sem Roentgenol"},{"key":"161_CR25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","volume":"18","author":"RHJA Slart","year":"2017","unstructured":"Slart RHJA, Glaudemans AWJM, Lancellotti P, et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. Eur Heart J Cardiovasc Imaging. 2017;18:1073\u201389.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"161_CR26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.semnuclmed.2018.02.005","volume":"48","author":"E Piekarski","year":"2018","unstructured":"Piekarski E, Benali K, Rouzet F. Nuclear imaging in sarcoidosis. Semin Nucl Med. 2018;48(3):246\u201360.","journal-title":"Semin Nucl Med"},{"issue":"3","key":"161_CR27","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/jcm9030890","volume":"9","author":"RGM Keijsers","year":"2020","unstructured":"Keijsers RGM, Grutters JC. In Which Patients with\u00a0Sarcoidosis\u00a0Is FDG PET\/CT Indicated? J Clin Med. 2020;9(3):890. https:\/\/doi.org\/10.3390\/jcm9030890.","journal-title":"J Clin Med"},{"issue":"1","key":"161_CR28","doi-asserted-by":"crossref","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","volume":"11","author":"T Vita","year":"2018","unstructured":"Vita T, Okada DR, Veillet-Chowdhury M, et al. Complementary value of cardiac Magnetic Resonance Imaging and Positron Emission Tomography\/Computed Tomography in the assessment of cardiac\u00a0sarcoidosis. Circ Cardiovasc Imaging. 2018;11(1):e007030.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"161_CR29","doi-asserted-by":"crossref","first-page":"e00740","DOI":"10.1161\/CIRCIMAGING.117.007408","volume":"11","author":"EJ Miller","year":"2018","unstructured":"Miller EJ, Culver DA. Establishing an evidence-based method to diagnose cardiac\u00a0sarcoidosis: the complementary use of cardiac Magnetic Resonance Imaging and FDG-PET. Circ Cardiovasc Imaging. 2018;11(1):e00740.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"161_CR30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/resp.13537","volume":"24","author":"R Trisolini","year":"2019","unstructured":"Trisolini R, Baughman RP, Spagnolo P, Culver DA. Endobronchial ultrasound-guided transbronchial needle aspiration in sarcoidosis: beyond the diagnostic yield. Respirology. 2019;24(6):531\u201342.","journal-title":"Respirology"},{"issue":"12","key":"161_CR31","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer KC, Raghu G, Baughman RP, et al. An Official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(12):1004\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"161_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00608-5","author":"M d'Alessandro","year":"2020","unstructured":"d\u2019Alessandro M, Carleo A, Cameli P, et al. BAL biomarkers\u2019 panel for differential diagnosis of interstitial lung diseases. Clin Exp Med. 2020. https:\/\/doi.org\/10.1007\/s10238-020-00608-5.","journal-title":"Clin Exp Med"},{"key":"161_CR33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.06-2822","volume":"132","author":"RP Baughman","year":"2007","unstructured":"Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest. 2007;132:207\u201313.","journal-title":"Chest"},{"issue":"11","key":"161_CR34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","volume":"12","author":"A Chopra","year":"2016","unstructured":"Chopra A, Kalkanis A, Judson MA. Biomarkers in sarcoidosis. Exp Rev Clin Immunol. 2016;12(11):1191\u2013208.","journal-title":"Exp Rev Clin Immunol"},{"issue":"4","key":"161_CR35","doi-asserted-by":"publisher","first-page":"00094","DOI":"10.1183\/23120541.00094-2019","volume":"5","author":"NA Kampstra","year":"2019","unstructured":"Kampstra NA, van der Nat PB, Dijksman LM, et al. Results of the standard set for pulmonary\u00a0sarcoidosis: feasibility and multicentre outcomes. ERJ Open Res. 2019 Oct 30;5(4):00094\u20132019. https:\/\/doi.org\/10.1183\/23120541.00094-2019.","journal-title":"ERJ Open Res."},{"key":"161_CR36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/jovr.jovr_201_17","volume":"13","author":"AE El Ameen","year":"2018","unstructured":"El Ameen AE, Herbort CP Jr. Comparison of retinal and choroidal involvement in sarcoidosis-related chorioretinitis using fluorescein and indocyanine green angiography. J Ophtalmic Vis Res. 2018;13:426\u201332.","journal-title":"J Ophtalmic Vis Res"},{"issue":"2","key":"161_CR37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/jamaophthalmol.2017.5466","volume":"136","author":"YS Han","year":"2018","unstructured":"Han YS, Rivera-Grana E, Salek S, Rosenbaum JT. Distinguishing uveitis secondary to sarcoidosis from idiopathic disease: cardiac implications. JAMA Ophthalmol. 2018;136(2):109\u201315.","journal-title":"JAMA Ophthalmol"},{"key":"161_CR38","doi-asserted-by":"crossref","unstructured":"Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharaya NR, Rao NA, for the International Workshop on Ocular Sarcoidosis Study Group. Revised criteria International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis.\u00a0Br J Ophthamol\u00a02019; 103(10):1418\u20131422","DOI":"10.1136\/bjophthalmol-2018-313356"},{"issue":"12","key":"161_CR39","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","volume":"75","author":"BJ Stern","year":"2018","unstructured":"Stern BJ, Royal W 3rd, Gelfand JM, et al. Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018;75(12):1546\u201353.","journal-title":"JAMA Neurol"},{"issue":"10","key":"161_CR40","doi-asserted-by":"publisher","first-page":"796.e1","DOI":"10.1016\/j.crad.2020.05.008","volume":"75","author":"G Bathla","year":"2020","unstructured":"Bathla G, Freeman CW, Moritani T, Song JW, Srivastava S, Soni N, Derdeyn C, Mohan S. Retrospective, dual-centre review of imaging findings in neurosarcoidosis at presentation: prevalence and imaging sub-types. Clin Radiol. 2020;75(10):796.e1-796.e9. https:\/\/doi.org\/10.1016\/j.crad.2020.05.008.","journal-title":"Clin Radiol"},{"issue":"2","key":"161_CR41","first-page":"135","volume":"124","author":"D Saygin","year":"2020","unstructured":"Saygin D, Jones S, Sundaram P, Calabrese LH, Messner W, Tavee JO, Hajj-Ali RA. Differentiation between\u00a0neurosarcoidosis\u00a0and primary central nervous system vasculitis based on demographic, cerebrospinal and\u00a0imaging\u00a0features. Clin Exp Rheumatol. 2020;124(2):135\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"161_CR42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11916-011-0180-8","volume":"15","author":"J Tavee","year":"2011","unstructured":"Tavee J, Culver D. Sarcoidosis and small-fiber neuropathy. Curr Pain Headache Rep. 2011;15(3):201\u20136.","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"161_CR43","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10072-019-03871-x","volume":"40","author":"NY Basantsova","year":"2019","unstructured":"Basantsova NY, Starshinova AA, Dori A, Zinchenko YS, Yablonskiy PK, Shoenfeld Y. Small-fiber neuropathy definition, diagnosis, and treatment. Neurol Sci. 2019;40(7):1343\u20132135.","journal-title":"Neurol Sci"},{"issue":"1","key":"161_CR44","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1038\/s41598-018-23107-w","volume":"8","author":"M Brines","year":"2018","unstructured":"Brines M, Culver DA, Ferdousi M, Tannemaat MR, van Velzen M, Dahan A, Malik RA. Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy. Sci Rep. 2018;8(1):4734.","journal-title":"Sci Rep"},{"issue":"4","key":"161_CR45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","volume":"68","author":"DH Birnie","year":"2016","unstructured":"Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68(4):411\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"161_CR46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2017.09.204","volume":"253","author":"D Juneau","year":"2018","unstructured":"Juneau D, Nery P, Russo J, de Kemp RA, Leung E, Beanlands RSB, Birnie DH. How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body 18F-fluorodeoxyglucose positron emission tomography. Int J Cardiol. 2018;253:189\u201393.","journal-title":"Int J Cardiol"},{"issue":"7","key":"161_CR47","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305\u201312.","journal-title":"Heart Rhythm"},{"key":"161_CR48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","volume":"3","author":"F Terasaki","year":"2017","unstructured":"Terasaki F, Yoshinaga K. New guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol. 2017;3:42\u20135.","journal-title":"Ann Nucl Cardiol"},{"issue":"8","key":"161_CR49","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","volume":"58","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W, on behalf of the group, et al. Joint SNMMI-ASNC Expert Consensus Document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58(8):1341\u201353.","journal-title":"J Nucl Med"},{"issue":"7","key":"161_CR50","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.pathol.2017.08.004","volume":"49","author":"T Khan","year":"2017","unstructured":"Khan T, Selvakumar D, Trivedi S, Rao K, Harapoz M, Thiagalingam A, Denniss AR, Varikatt W. The value of endomyocardial biopsy in diagnosis and guiding therapy. Pathology. 2017;49(7):750\u20136.","journal-title":"Pathology"},{"issue":"12","key":"161_CR51","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.rmed.2013.10.014","volume":"107","author":"RP Baughman","year":"2013","unstructured":"Baughman RP, Lower EE. Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients. Respir Med. 2013;107(12):2009\u201313.","journal-title":"Respir Med"},{"issue":"49","key":"161_CR52","doi-asserted-by":"crossref","first-page":"e8846","DOI":"10.1097\/MD.0000000000008846","volume":"96","author":"A Dur\u00e9ault","year":"2017","unstructured":"Dur\u00e9ault A, Chapelon C, Biard L, et al. Severe infections in sarcoidosis: Incidence, predictors and long-term outcome in a cohort of 585 patients. Medicine (Baltimore). 2017;96(49):e8846.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"161_CR53","doi-asserted-by":"crossref","first-page":"e9088","DOI":"10.1371\/journal.pone.0009088","volume":"5","author":"NJ Sweiss","year":"2010","unstructured":"Sweiss NJ, Salloum R, Gandhi S, et al. Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations. PLoS ONE. 2010;5(2):e9088.","journal-title":"PLoS ONE"},{"issue":"6","key":"161_CR54","doi-asserted-by":"publisher","first-page":"1602396","DOI":"10.1183\/13993003.02396-201","volume":"49","author":"Y Uzunhan","year":"2017","unstructured":"Uzunhan Y, Nunes H, Jeny F, et al. Chronic pulmonary aspergillosis complicating\u00a0sarcoidosis. Eur Respir J. 2017;49(6):1602396. https:\/\/doi.org\/10.1183\/13993003.02396-201.","journal-title":"Eur Respir J"},{"issue":"4","key":"161_CR55","doi-asserted-by":"publisher","first-page":"1700465","DOI":"10.1183\/13993003.00465-2017","volume":"50","author":"A Boucly","year":"2017","unstructured":"Boucly A, Cottin V, Nunes H, et al. Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension. Eur Respir J. 2017;50(4):1700465. https:\/\/doi.org\/10.1183\/13993003.00465-2017.","journal-title":"Eur Respir J"},{"issue":"2","key":"161_CR56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00408-017-0076-4","volume":"196","author":"P Brito-Zer\u00f3n","year":"2018","unstructured":"Brito-Zer\u00f3n P, Acar-Denizli N, Sis\u00f3-Almirall A, et al. The burden of comorbidity and complexity in sarcoidosis: impact of associated chronic diseases. Lung. 2018;196(2):239\u201348.","journal-title":"Lung"},{"key":"161_CR57","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00198-015-3426-1","volume":"27","author":"S Bours","year":"2016","unstructured":"Bours S, de Vries F, van der Bergh JPW, et al. Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort. Osteoporos Int. 2016;27:1603\u201310.","journal-title":"Osteoporos Int"},{"key":"161_CR58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chest.2016.09.009","volume":"151","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Crowson CS, Matteson EL. Association of sarcoidosis with increased risk of VTE: a population-based study. 1976 to 2013. Chest. 2017;151:425\u201330.","journal-title":"Chest"},{"issue":"2","key":"161_CR59","doi-asserted-by":"publisher","first-page":"1601290","DOI":"10.1183\/13993003.01290-2016","volume":"49","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Crowson CS, Matteson EL. Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976\u20132013. Eur Respir J. 2017;49(2):1601290. https:\/\/doi.org\/10.1183\/13993003.01290-2016.","journal-title":"Eur Respir J"},{"issue":"4","key":"161_CR60","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1346-8138.13654","volume":"44","author":"C-H Wu","year":"2017","unstructured":"Wu C-H, Chung PI, Wu CY, Chen YT, Chiu YW, Chang YT. Liu HN Comorbid autoimmune diseases in patients with sarcoidosis: a nationwide case-control study in Taiwan. J Dermatol. 2017;44(4):423\u201330.","journal-title":"J Dermatol"},{"key":"161_CR61","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.rmed.2017.11.008","volume":"138S","author":"C Hendriks","year":"2018","unstructured":"Hendriks C, Drent M, De Kleijn W, Elfferich M, Wijnen P, De Vries J. Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a prospective follow-up study. Respir Med. 2018;138S:S24\u201330.","journal-title":"Respir Med"},{"key":"161_CR62","first-page":"56","volume":"28","author":"RP Baughman","year":"2011","unstructured":"Baughman RP, Nagai S, Balter M, et al. Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28:56\u201364.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"161_CR63","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","volume":"109","author":"MA Judson","year":"2015","unstructured":"Judson MA, Chaudhry H, Louis A, Lee K, Yucel R. The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis. Respir Med. 2015;109(4):526\u201331.","journal-title":"Respir Med"},{"issue":"1","key":"161_CR64","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/IAE.0000000000001128","volume":"37","author":"A Invernizzi","year":"2017","unstructured":"Invernizzi A, Agarwal A, Mapelli C, Nguyen QD, Staurenghi G, Viola F. Longitudinal follow-up of choroidal granulomas using enhanced depth imaging optical coherence tomography. Retina. 2017;37(1):144\u201353.","journal-title":"Retina"},{"issue":"4","key":"161_CR65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","volume":"25","author":"N Ning","year":"2019","unstructured":"Ning N, Guo HH, Iagaru A, Mittra E, Fowler M, Witteles R. Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis. J Card Fail. 2019;25(4):307\u201311.","journal-title":"J Card Fail"},{"key":"161_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.12.013","author":"DR Oakada","year":"2020","unstructured":"Oakada DR, Saad E, Wand AL, et al. Effect of corticosteroid dose and duration on 18-fluorodeoxyglucose positron Emission Tomography in cardiac sarcoidosis. JACC Cardiovasc Imaging. 2020. https:\/\/doi.org\/10.1016\/j.jcmg.2019.12.013.","journal-title":"JACC Cardiovasc Imaging"},{"key":"161_CR67","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1536\/ihj.17-695","volume":"59","author":"T Kiko","year":"2018","unstructured":"Kiko T, Yoshihisa A, Kanno Y, et al. A multiple biomarker approach in patients with cardiac sarcoidosis. Int Heart J. 2018;59:996\u2013100.","journal-title":"Int Heart J"},{"key":"161_CR68","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1378\/chest.12-1060","volume":"142","author":"E Panselinas","year":"2012","unstructured":"Panselinas E, Judson MA. Acute pulmonary exacerbations of sarcoidosis. Chest. 2012;142:827\u201336.","journal-title":"Chest"},{"issue":"155","key":"161_CR69","doi-asserted-by":"publisher","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","volume":"29","author":"FF Rahaghi","year":"2020","unstructured":"Rahaghi FF, Baughman RP, Saketkoo LA, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary\u00a0sarcoidosis. Eur Respir Rev. 2020;29(155):190146. https:\/\/doi.org\/10.1183\/16000617.0146-2019.","journal-title":"Eur Respir Rev"},{"key":"161_CR70","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01747-2019","author":"OA Shlobin","year":"2020","unstructured":"Shlobin OA, Kouranos V, Barnett SD, et al. Physiological Predictors of Survival in Patients with\u00a0Sarcoidosis\u00a0Associated Pulmonary Hypertension: Results from an International Registry. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.01747-2019.","journal-title":"Eur Respir J"},{"issue":"36","key":"161_CR71","doi-asserted-by":"crossref","first-page":"e12205","DOI":"10.1097\/MD.0000000000012205","volume":"97","author":"J Duan","year":"2018","unstructured":"Duan J, Xu Y, Zhu H, et al. Relationship between CT activity\u00a0score\u00a0with lung function and the serum angiotensin converting enzyme in pulmonary\u00a0sarcoidosis\u00a0on chest HRCT. Medicine (Baltimore). 2018;97(36):e12205.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"161_CR72","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1164\/rccm.200211-1343OC","volume":"168","author":"CE Cox","year":"2003","unstructured":"Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am J Respir Crit Care Med. 2003;168(3):323\u20139. https:\/\/doi.org\/10.1164\/rccm.200211-1343OC (Epub 2003 May 8PMID: 12738606).","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"161_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","volume":"68","author":"AS Patel","year":"2013","unstructured":"Patel AS, Siegert RJ, Creamer D, et al. The development and validation of the King\u2019s Sarcoidosis Questionnaire for the assessment of health status. Thorax. 2013 Jan;68(1):57\u201365. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-201962 (Epub 2012 Oct 12PMID: 23065052).","journal-title":"Thorax"},{"issue":"7","key":"161_CR74","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC.PMID","volume":"191","author":"MA Judson","year":"2015","unstructured":"Judson MA, Mack M, Beaumont JL, Watt R, Barnathan ES, Victorson DE. Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure. Am J Respir Crit Care Med. 2015;191(7):786\u201395. https:\/\/doi.org\/10.1164\/rccm.201410-1785OC.PMID.","journal-title":"Am J Respir Crit Care Med"},{"key":"161_CR75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1348\/1359107041557048","volume":"9","author":"J de Vries","year":"2004","unstructured":"de Vries J, Michielsen HJ, van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol. 2004;9:279\u201391.","journal-title":"Br J Health Psychol"},{"issue":"3","key":"161_CR76","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","volume":"195","author":"RP Baughman","year":"2017","unstructured":"Baughman RP, Sweiss N, Keijsers R, Birring SS, Shipley R, Saketkoo LA, Lower EE. Repository corticotropin for chronic pulmonary sarcoidosis. Lung. 2017;195(3):313\u201322.","journal-title":"Lung"},{"issue":"1","key":"161_CR77","doi-asserted-by":"crossref","first-page":"000394","DOI":"10.1136\/bmjresp-2018-000394","volume":"6","author":"NA Kampstra","year":"2019","unstructured":"Kampstra NA, Grutters JC, van Beek FT, et al. First patient-centred set of outcomes for pulmonary\u00a0sarcoidosis: a multicentre initiative. BMJ Open Respir Res. 2019;6(1):000394.","journal-title":"BMJ Open Respir Res"},{"issue":"6","key":"161_CR78","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12026-020-09158-0","volume":"68","author":"L Bergantini","year":"2020","unstructured":"Bergantini L, d\u2019Alessandro M, Vietri L, et al. Utility of serological biomarker\u2019 panels for diagnostic accuracy of interstitial lung diseases. Immunol Res. 2020;68(6):414\u201321. https:\/\/doi.org\/10.1007\/s12026-020-09158-0 (Epub 2020 Oct 22. PMID: 33089426; PMCID: PMC7674352).","journal-title":"Immunol Res"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-021-00161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-021-00161-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-021-00161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T11:23:39Z","timestamp":1636716219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-021-00161-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,6]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1007\/s41030-021-00161-w","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,6]]},"assertion":[{"value":"30 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}